# Glenmark Pharmaceuticals Ltd - Inspection Records

Source: https://www.keypedia.com/companies/glenmark-pharmaceuticals-ltd/1e6c03ca-7a68-4506-9af3-70d64338538a

> Inspection records and compliance data for Glenmark Pharmaceuticals Ltd in Pithampur, None. Access full analysis and detailed observations.

---

## Details

- Name: Glenmark Pharmaceuticals Ltd
- FEI Number: 3008565058
- City: Pithampur
- State: None
- Country Name: India
- Address Line 1: Plot No 2, Phase - 2 Pharma Zone Sez
- Zip Code: None
- Facility Type: Finished Oral Solid Dosage Manufacturer
- Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK

## Related Documents

- [483 - Glenmark Pharmaceuticals Ltd - 2025-02-14](https://www.keypedia.com/records/483/glenmark-pharmaceuticals-ltd/7fc0fee9-6198-4c85-9a5b-f21fd1449ab8) — source: FDA, date: February 14, 2025
- [483 - Glenmark Pharmaceuticals Ltd - 2025-02-14](https://www.keypedia.com/records/483/glenmark-pharmaceuticals-ltd/1cc89a1d-cf2b-4d72-9e95-834b6d737023) — source: FDA, date: February 14, 2025
- [WARNING_LETTER - Glenmark Pharmaceuticals Ltd - 2025-02-14](https://www.keypedia.com/records/warning_letter/glenmark-pharmaceuticals-ltd/f05498db-6645-42ab-81ff-8a03eb201f2f) — source: FDA, date: February 14, 2025
- [483 - Glenmark Pharmaceuticals Ltd - 2025-02-14](https://www.keypedia.com/records/483/glenmark-pharmaceuticals-ltd/0ced202b-767c-4244-95f5-a3ab861a6b47) — source: FDA, date: February 14, 2025
- [FDA Inspection 1260403 - Glenmark Pharmaceuticals Ltd - 2025-02-14](https://www.keypedia.com/records/fda_inspections/glenmark-pharmaceuticals-ltd/3c60fd16-c7cf-4f81-84b6-49d9b508a8a5) — source: FDA, date: February 14, 2025
- [FDA Inspection 1260403 - Glenmark Pharmaceuticals Ltd - 2025-02-14](https://www.keypedia.com/records/fda_inspections/glenmark-pharmaceuticals-ltd/135e2ceb-8fc0-4f1b-85f4-7dd2405c8793) — classification: Official Action Indicated (OAI), source: FDA, date: February 14, 2025
- [FDA Inspection 1122868 - Glenmark Pharmaceuticals Ltd - 2020-02-25](https://www.keypedia.com/records/fda_inspections/glenmark-pharmaceuticals-ltd/d660f074-743b-4d49-9676-d23b1a8f3af3) — classification: No Action Indicated (NAI), source: FDA, date: February 25, 2020
- [FDA Inspection 1107098 - Glenmark Pharmaceuticals Ltd - 2019-09-13](https://www.keypedia.com/records/fda_inspections/glenmark-pharmaceuticals-ltd/71212f99-083e-4703-bd7e-29af24033c10) — classification: No Action Indicated (NAI), source: FDA, date: September 13, 2019
- [483 - Glenmark Pharmaceuticals Ltd - 2018-05-24](https://www.keypedia.com/records/483/glenmark-pharmaceuticals-ltd/7fe7f73b-7011-4b70-82e3-f637a3a418ec) — source: FDA, date: May 24, 2018
- [FDA Inspection 1053034 - Glenmark Pharmaceuticals Ltd - 2018-05-24](https://www.keypedia.com/records/fda_inspections/glenmark-pharmaceuticals-ltd/d58dd996-cd4c-4c93-a806-807c622ee6c3) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 24, 2018
- [FDA Inspection 1028538 - Glenmark Pharmaceuticals Ltd - 2017-08-26](https://www.keypedia.com/records/fda_inspections/glenmark-pharmaceuticals-ltd/4a9b33f4-46ae-4dd5-ac8d-e581ed33dbeb) — classification: No Action Indicated (NAI), source: FDA, date: August 26, 2017
- [FDA Inspection 962557 - Glenmark Pharmaceuticals Ltd - 2016-02-26](https://www.keypedia.com/records/fda_inspections/glenmark-pharmaceuticals-ltd/ba4a8656-dfe3-4b6e-bdf3-dc6d2c4a55c2) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 26, 2016
- [FDA Inspection 935717 - Glenmark Pharmaceuticals Ltd - 2015-07-24](https://www.keypedia.com/records/fda_inspections/glenmark-pharmaceuticals-ltd/fa315b2f-2756-41bd-a316-633e2e4717e1) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 24, 2015
- [FDA Inspection 854874 - Glenmark Pharmaceuticals Ltd - 2013-10-25](https://www.keypedia.com/records/fda_inspections/glenmark-pharmaceuticals-ltd/0a959e07-19cd-4a23-8f12-ec8439deede6) — classification: No Action Indicated (NAI), source: FDA, date: October 25, 2013

## Related Companies

- [Pfizer Manufacturing Belgium NV](https://www.keypedia.com/companies/pfizer-manufacturing-belgium-nv/9251b625-0cd3-4c3e-8267-f0c88fe32d75)
- [Excelvision](https://www.keypedia.com/companies/excelvision/b2c65dbb-dd32-400c-80ab-c6feab10deab)
- [DPT Laboratories Ltd](https://www.keypedia.com/companies/dpt-laboratories-ltd/b2d45aa5-6cf4-4401-87a2-35470321dc30)
- [Mission Pharmacal Company](https://www.keypedia.com/companies/mission-pharmacal-company/91da96fe-b7e4-449c-b2cc-53a57bd7f2b6)
- [Pharmco Laboratories Inc.](https://www.keypedia.com/companies/pharmco-laboratories-inc/b34e3481-0ea5-433a-9e03-ce66b44df443)
- [MSD International GmbH (Puerto Rico Branch) LLC](https://www.keypedia.com/companies/msd-international-gmbh-puerto-rico-branch-llc/98d0fc68-f819-4431-899c-0483c3329777)
- [Tom's of Maine, Inc.](https://www.keypedia.com/companies/toms-of-maine-inc/4b3b44e0-d661-40b1-b271-61a8f81eccf7)
- [Genentech, Inc.](https://www.keypedia.com/companies/genentech-inc/97918967-ab2f-4019-9954-a0d687852d27)
- [Bora Pharmaceuticals Injectables Inc](https://www.keypedia.com/companies/bora-pharmaceuticals-injectables-inc/d6e15b21-41fb-4f18-9638-893d3f44fcd1)
- [Sciegen Pharmaceuticals Inc](https://www.keypedia.com/companies/sciegen-pharmaceuticals-inc/814ff2a4-e264-431f-bffa-9932abda619d)

## Related Officers

- [Arsen Karapetyan](https://www.keypedia.com/people/arsen-karapetyan/4000d909-277b-4533-992f-4e3627c8ce40)
- [Pratik S. Upadhyay](https://www.keypedia.com/people/pratik-s-upadhyay/22ff2e0b-17d4-4c91-a3f0-c7e30b7a115b)
- [Saleem A. Akhtar](https://www.keypedia.com/people/saleem-a-akhtar/1ea49212-bea5-4d43-bd0a-cdede4d3b1cf)
- [Consumer Safety Officer - Dedicated Foreign Drug Cadre](https://www.keypedia.com/people/tamil-arasu/94efc491-7d9f-4221-a1ee-69a925acb1c3)